OBJECTIVES: To develop and validate a prediction model for the early identification of children with pneumonia in emergency care settings. METHODS: This was a diagnostic study with derivation and validation of multivariate logistic regression models. This study was carried out on children aged 1 month-16 years presenting with fever and cough visiting the pediatric emergency department of the Erasmus MC-Sophia, Rotterdam, the Netherlands (derivation population, n=504); Pediatric Assessment Unit, University Hospitals Coventry and Warwickshire NHS Trust, UK (validation population 1, n=420); Accident & Emergency Department, Queen's Medical Centre, Nottingham, UK (validation population 2, n=366). The outcome pneumonia is defined by the presence of pulmonary consolidations on chest radiograph or follow-up. RESULTS: In population 1, 78 (16%) children were diagnosed with pneumonia; in populations 2 and 3, this number was 58 (14%) and 27 (7%), respectively. A simple clinical decision rule on the basis of ill appearance, tachypnea, decreased oxygen saturation, and elevated serum C-reactive protein categorized children as being at a low (<5%) or a high (>16%) risk of pneumonia. The rule yielded a discriminative value of 0.79 (0.69-0.89) in the Rotterdam population and was validated well in the other two populations. CONCLUSION: The risk of pneumonia can be assessed using three key clinical characteristics - overall assessment of the severity of illness, breathing rate, and oxygen saturation. Serum C-reactive protein contributes to the prediction of an intermediate risk of pneumonia in children. Children with a low risk of developing pneumonia with vital signs in the normal range can be discharged with effective safety netting, requiring neither antibiotics nor radiographs.
OBJECTIVES: To develop and validate a prediction model for the early identification of children with pneumonia in emergency care settings. METHODS: This was a diagnostic study with derivation and validation of multivariate logistic regression models. This study was carried out on children aged 1 month-16 years presenting with fever and cough visiting the pediatric emergency department of the Erasmus MC-Sophia, Rotterdam, the Netherlands (derivation population, n=504); Pediatric Assessment Unit, University Hospitals Coventry and Warwickshire NHS Trust, UK (validation population 1, n=420); Accident & Emergency Department, Queen's Medical Centre, Nottingham, UK (validation population 2, n=366). The outcome pneumonia is defined by the presence of pulmonary consolidations on chest radiograph or follow-up. RESULTS: In population 1, 78 (16%) children were diagnosed with pneumonia; in populations 2 and 3, this number was 58 (14%) and 27 (7%), respectively. A simple clinical decision rule on the basis of ill appearance, tachypnea, decreased oxygen saturation, and elevated serum C-reactive protein categorized children as being at a low (<5%) or a high (>16%) risk of pneumonia. The rule yielded a discriminative value of 0.79 (0.69-0.89) in the Rotterdam population and was validated well in the other two populations. CONCLUSION: The risk of pneumonia can be assessed using three key clinical characteristics - overall assessment of the severity of illness, breathing rate, and oxygen saturation. Serum C-reactive protein contributes to the prediction of an intermediate risk of pneumonia in children. Children with a low risk of developing pneumonia with vital signs in the normal range can be discharged with effective safety netting, requiring neither antibiotics nor radiographs.
Authors: Are Stuwitz Berg; Christopher Stephen Inchley; Hans Olav Fjaerli; Truls Michael Leegaard; Morten Lindbaek; Britt Nakstad Journal: Eur J Pediatr Date: 2017-03-09 Impact factor: 3.183
Authors: Fleur M Moesker; Jeroen J A van Kampen; Annemarie M C van Rossum; Matthijs de Hoog; Marion P G Koopmans; Albert D M E Osterhaus; Pieter L A Fraaij Journal: PLoS One Date: 2016-03-10 Impact factor: 3.240
Authors: Mark D Lyttle; Julia A Bielicki; Sam Barratt; David Dunn; Adam Finn; Lynda Harper; Pauline Jackson; Colin V E Powell; Damian Roland; Wolfgang Stohr; Kate Sturgeon; Mandy Wan; Paul Little; Saul N Faust; Julie Robotham; Alastair D Hay; Diana M Gibb; Mike Sharland Journal: BMJ Open Date: 2019-05-22 Impact factor: 2.692
Authors: F M Moesker; J J A van Kampen; A A van der Eijk; A M C van Rossum; M de Hoog; M Schutten; S L Smits; R Bodewes; A D M E Osterhaus; P L A Fraaij Journal: Clin Microbiol Infect Date: 2015-06-19 Impact factor: 8.067
Authors: Jennifer L Lenahan; Evangelyn Nkwopara; Melda Phiri; Tisungane Mvalo; Mari T Couasnon; Kali Turner; Chifundo Ndamala; Eric D McCollum; Susanne May; Amy Sarah Ginsburg Journal: ERJ Open Res Date: 2020-05-26
Authors: Alastair D Hay; Niamh M Redmond; Sophie Turnbull; Hannah Christensen; Hannah Thornton; Paul Little; Matthew Thompson; Brendan Delaney; Andrew M Lovering; Peter Muir; John P Leeming; Barry Vipond; Beth Stuart; Tim J Peters; Peter S Blair Journal: Lancet Respir Med Date: 2016-09-01 Impact factor: 30.700
Authors: Marjolein J C Schot; Anne R J Dekker; Wesley G Giorgi; Rogier M Hopstaken; Niek J de Wit; Theo J M Verheij; Jochen W L Cals Journal: NPJ Prim Care Respir Med Date: 2018-10-26 Impact factor: 2.871